Biogen Idec's 'Plegridy' therapy for multiple sclerosis delayed by FDA

Home › Biogen Idec's 'Plegridy' therapy for multiple sclerosis delayed by FDA

Two new multiple sclerosis pills have hit the market and a third is on the way to replace shots with potentially serious side effects.

05.07	Tropical Storm Beryl Graphics
05.07	Atlantic Tropical Weather Outlook
05.07	Tropical Storm Beryl Public Advisory Number 28A
05.07	Summary for Tropical Storm Beryl (AT2/AL022024)
05.07	Eastern North Pacific Tropical Weather Outlook
05.07	Tubi and Pluto lead U.S. surge in free streaming
05.07	Tubi free streaming service launches in the UK
05.07	Simplestream reveals preferred technology partnership with Freely
More »

je.st